After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...

(CNN) – The crackdown on off-brand weight loss and diabetes treatment drugs is about to take effect, meaning supplies for the treatments are likely to tighten. A federal deadline to halt sales of the ...

The Danish drugmaker unveiled a series of initiatives to increase access to Wegovy and clamp down on use of the knock-off ...

I t’s hard to argue that the introduction of drugs like Ozempic has been anything short of revolutionary for people looking ...

Amble Health's website states it is a platform connecting patients to licensed healthcare professionals online, who can ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

After the the FDA declared an end to the shortage of GLP-1 medications, compounded versions of the drug must be out of the market by Thursday.

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Lawsuits are piling up as weight-loss drug users report losing their sight: ‘I definitely wouldn’t have taken it’ - Edward ...